Those with higher BSG expression had significantly worse five- and ten-year overall survival than patients with lower BSG expression (Supplementary Figure S4A), suggesting that the expression level of BSG may represent a negative prognostic factor for overall survival in medulloblastoma patients. This evidence concerns the gene BSG and medulloblastoma.